Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home treatment of elderly patients with symptomatic SARS-CoV-2 infection (COVID-19): multiarm, multi-stage randomized trial
2020-001435-27Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of imatinib, favipiravir and telmisartan in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Hospitalization or death by day 14. Started Apr 2020; status: completed.
02
Drugs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001435-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001435-27.